Sad news: WHO estimates over 200 million people worldwide have suffered from Long Covid symptoms, the most common being exhaustion and cognitive difficulties. Early on, some victims seemed to benefit from vaccination. Pretty soon some studies of monoclonal antibodies for Long Covid may start, but the problem is which monoclonal? We have a battlefield littered with useless monoclonals as they are quite variant-specific.

Active immunity following vaccinations or multiple infections promote some great things like somatic hypermutation and affinity maturation, which make antibodies against every variant possible and antibodies that are 1000s of times better at neutralizing virus respectfully. Passive immunity (monoclonals) do not. Antivirals and monoclonals are wonderful, but they might actually prevent a robust immune response that can give you T and B-cell immunity that can last for many years. (17 years so far for SARS victims who survived.)